Pharmaceutical companies stalling on plant construction plan

Reflecting increasing uncertainty in the domestic pharmaceutical industry due to the government’s plan to cut drug prices starting next year, big corporations, Dong-A and Daewoong, are delaying the construction or re-modeling plan of their plants for next year.

They say that things are put on hold, not knowing what to expect next year.

"We are in a holding pattern of sorts," a Dong-A spok...